![Erica Whittaker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erica Whittaker
Direttore/Membro del Consiglio presso
Neurona Therapeutics, Inc.
Profilo
Erica Whittaker is currently a Director at Neurona Therapeutics, Inc. and a Director at StrideBio, Inc. She is also a Director at SpliceBio SL, UCB Ventures (Private Equity), Rinri Therapeutics Ltd., and Exevir Bio BV.
Previously, she worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith Ltd.
Posizioni attive di Erica Whittaker
| Società | Posizione | Inizio |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Direttore/Membro del Consiglio | 22/06/2021 |
UCB Ventures London
 UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Investitore di Private Equity | 01/10/2017 |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Direttore/Membro del Consiglio | - |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Direttore/Membro del Consiglio | 14/06/2018 |
Rinri Therapeutics Ltd.
 Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Direttore/Membro del Consiglio | 01/02/2021 |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Direttore/Membro del Consiglio | - |
UCB Ventures (Private Equity)
 UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Erica Whittaker
| Società | Posizione | Fine |
|---|---|---|
Merrill Lynch, Pierce, Fenner & Smith Ltd.
 Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2009 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
4
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith Ltd.
Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Finance |
UCB Ventures London
UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Finance |
Rinri Therapeutics Ltd.
Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Commercial Services |
Exevir Bio BV
Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Health Technology |
